γ-H2AX- A novel biomaker for DNA double-strand breaks

In Vivo

Volumn 22, Issue 3, 2008, Pages 305-310

  Kuo, Linda J ^a   Yang, Li Xi ^a,b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b ST MARY S MEDICAL CENTER   (United States)

Author keywords

DNA breaks; DNA damage and repair; H2AX; Lethal damage; Review

Indexed keywords

BIOLOGICAL MARKER; BLEOMYCIN; CAMPTOTHECIN; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; GAMMA HISTONE H2AX; GEMCITABINE; GYRASE INHIBITOR; HISTONE H2AX; HYDROXYUREA; MITOXANTRONE; TIRAPAZAMINE; TOPOTECAN; VORINOSTAT; ZINOSTATIN;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; IONIZING RADIATION; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIOSENSITIVITY; REVIEW;

EID: 45949109186     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Kobayashi J: Molecular mechanism of the recruitment of NBS1/hMRE11/ hRAD50 complex to DNA double-strand breaks: NBS1 binds to γ-H2AX through FHA/BRCT domain. J Radiat Res 45: 473-478, 2004.
2. Foster ER and Downs JA: Histone H2A phosphorylation in DNA double-strand break repair. FEBS J 272: 3231-3240, 2005.
3. Ausio J and Abbott DW: The many tales of a tail: carboxy-terminal tail heterogeneity specializes histone H2A variants for defined chromatin function. Biochemistry 41: 5945-5949, 2002.
4. Rogakou EP, Pilch DR, Orr AH, Ivanova BS and Bonner WM: DNA Double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868, 1998.
5. Rogakou EP, Boon C, Redon C and Bonner WM: Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146: 905-916, 1999.
6. Pilch DR, Sedelnikova OA, Redon C, Celeste A, Nussenzweig A and Bonner WM: Characteristics of γ-H2AX foci at DNA double-strand break sites. Biochem Cell Biol 81: 123-129, 2003.
7. Lowndes NF and Toh GW: DNA repair: the importance of phosphorylating histone H2AX. Curr Biol 15: 99-102, 2005.
8. Burma S, Chen BP, Murphy M, Kurimasa A and Chen DJ: ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 276: 42462-42467, 2001.
9. Durocher D and Jackson SP: DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr Opin Cell Biol 13: 225-231, 2001.
10. Huang X, Traganos F and Darzynkiewicz Z: DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relations to the cell cycle phase and apoptosis. Cell Cycle 2: 614-619, 2003.
11. Ward IM and Chen J: Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 276: 47759-4776, 2001.
12. McManus KJ and Hendzel MJ: ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells. Mol Biol Cell 16: 5013-5025, 2005.
13. Unal E, Arbel-Eden A, Sattler U, Shroff R, Lichten M, Haber JE and Koshland D: DNA damage response pathway uses histone modification to assemble a double-strand break-specific cohesion domain. Mol Cell 16: 991-1002, 2004.
14. Chowdury D, Keogh M-C, Ishii H, Peterson CL, Buratowski S and Lieberman J: γ-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell 20: 801-809, 2005.
15. Li X, Melamed MR and Darzynkiewicz Z: Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color. Exp Cell Res 222: 28-37, 1996.
16. Kataoka Y, Binkdokas VP, Duggan RC, Murley JS and Grdina DJ: Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cells. J Radiat Res 47: 245-257, 2006.
17. Singh NP, McCoy MT, Tice RR and Schneider EL: Simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191, 1998.
18. Collins AR, Dobson VL, Dusinska M, Kennedy G and Stetina R: The comet assay: what can it really tell us? Mutat Res 375: 183-193, 1997.
19. Ismail IH, Wadhrall and Hammarsten O: An optimized method for detecting gamma-H2AX in blood cells reveals a significant interindividual variation in the gamma-H2AX response among humans. Nucleic Acids Res 35: e36, 2007.
20. Banath JP and Olive PL: Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-stranded breaks. Cancer Res 63: 4347-4350, 2003.
21. Banath JP, MacPhail SH and Olive PL: Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 64: 7144-7149, 2004.
22. MacPhail SH, Banath JP, Yu TY, Chu EHM, Lambur H and Olive PL: Expression of phosphorylated histone H2AX in cultured cell lines following exposure to x-rays. Int J Radiat Biol 79: 351-358, 2003.
23. Bassing CH, Chua YF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, Monroe BC, Ciccone DN, Yan C, Vlaskova K, Livingston DM, Ferguson DO, Scully R and Alt FW: Increased ionizing radiation sensitivity and geromic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 99: 8173-8178, 2002.
24. Huang X, Okafuji M, Traganos F, Luther E, Holden E and Darzynkiewicz Z: Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytometry A 58A: 99-110, 2004.
25. Ewald B, Sampath D and Plunkett W: H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol Cancer Ther 6: 1239-1248, 2007.
26. Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M, Gleason M, Bronson R, Lee C and Alt FW: Histone H2AX: a dosage dependent suppressor of oncogenic translocations and tumors. Cell 114: 359-370, 2003.
27. Hamada N, Schettino G, Kashino G, Vaid M, Suzuki K, Kodama S, Vojnovic B, Folkard M, Watanabe M, Michael BD and Prise KM: Histone H2AX phosphorylation in normal human cells irradiated with focused ultrasoft x rays: evidence for chromatin movement during repair. Radiat Res 166: 31-38, 2006.
28. Kao J, Milano MT, Javaheri A, Garofalo MC, Chmura SJ, Weichselbaum RR and Kron SJ: Gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy. Curr Cancer Drug Targets 6: 197-205, 2006.
29. Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ and Weichselbaum RR: Histone H2AX: phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 279: 2273-2280, 2004.
30. Klokov D, MacPhail SM, Banath JP, Byrne JP and Olive PL: Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol 80: 223-229, 2006.
31. Munshi A, Tanaka T, Hobbs ML, Tucker SL, Richon VM and Meyn RE: Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci. Mol Cancer Ther 5: 1967-1974, 2006.
32. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y and Bonner WM: Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 275: 9390-9395, 2000
33. Sedelnikova, OA, Pilch DR, Redon C and Bonner WM: Histone H2AX in DNA damage and repair. Cancer Biol Ther 2: 233-235, 2003.
34. Bocker W and Iliakis G: Computational methods for analysis of foci: validation for radiation-induced γ-H2AX foci in human cells. Radiat Res 165: 113-124, 2006.
35. Shay JW and Roninson IB: Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23: 2919-2933, 2004.